Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results.
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Writing Committee:; Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd.
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, et al.
Ophthalmology. 2020 Apr;127(4S):S135-S145. doi: 10.1016/j.ophtha.2020.01.029.
Ophthalmology. 2020.
PMID: 32200813
Clinical Trial.